
General Orthopaedics
Hemoglobin based oxygen carrier-201: A safe and effective way to save packed blood
J Trauma. 2008 Jun;64(6):1484-97.688 patients, older 18 years, undergoing non-emergency orthopedic surgery were randomized to treatment with hemoglobin based oxygen carrier-201 (HBOC-201) or packed RBC at the first transfusion decision. After 6 weeks, HBOC-201 was found to be a suitable alternative to packed red blood cell transfusion for patients younger than 80 years with moderate clinical need, undergoing elective orthopedic surgery. A comparison of safety between the two treatment arms was unfavorable for the HBOC-201 patients, but this might have been affected by the patient age.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.